A UPMC-led study suggests that healthcare professionals exposed to SARS-CoV-2 can safely return to work after seven days of quarantine if they are asymptomatic and receive a negative COVID-19 test. The findings, from the first reported study evaluating reduced quarantine duration in a healthcare setting, offer a potential new strategy for mitigating staffing shortages prior to a next wave of COVID-19 cases.
FDA approved Opdualag (nivolumab and relatlimab-rmbw) for adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma. Opdualag is a fixed-dose combination of the LAG-3-blocking antibody relatlimab and the programmed death receptor-1 blocking antibody nivolumab.
FDA approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for the treatment of adult patients with prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor pathway inhibition and taxane-based chemotherapy.
PathAI and Cleveland Clinic announced a five-year strategic collaboration leveraging PathAI’s quantitative pathology algorithms to conduct translational research and to use as clinical diagnostics in multiple disease areas.
Andrew Chapman was named director of the Sidney Kimmel Cancer Center – Jefferson Health (SKCC) and executive vice president of oncology services, effective March 15. Chapman has been serving as the center’s interim director for the past year.
Fight Colorectal Cancer hosted an advocacy event on the National Mall March 16, “Call-on Congress,” to discuss ways to reduce colorectal cancer incidence, improve treatment, and mitigate health disparities. The event included a flag installation on the Mall to honor those affected by CRC.
Camille Ragin was named associate director of diversity, equity, and inclusion at Fox Chase Cancer Center.
Ashish K. Jha, dean of Brown University’s School of Public Health, will succeed Jeffrey Zients to serve as the White House coronavirus response coordinator, at the request of President Joe Biden.
Martin S. Tallman was named director of faculty mentorship and career development at Lurie Cancer Center, effective June 1. Tallman will focus on the management and development of treatments for patients with both acute and chronic leukemias.
Dorothy Graves named assistant vice president and associate director for administration at Sylvester
Dorothy Graves was named assistant vice president and associate director for administration of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.
